Find your path to Orn
2 people in our graph share verified history with Orn — schools, employers, funds. One of them is your warm intro.
Árni BlöndalunlockedOrn: together at Axelyf
Orn: together at Axelyf
Founder at Axelyf
Intro paths
→
In turn, Orn can intro founders to Axelyf's investors below.
Axelyf's investors · 1
Experience
- AxelyfChief Executive Officercurrent2025 — presentMassachusetts, United States
- AxelyfCo-Foundercurrent2022 — presentHafnarfjörður, Capital Region, Iceland
- AxelyfChief Executive Officer2025 — 2026Massachusetts, United States
- UNSWVisiting Fellow, chemistry and RNA institutecurrent2022 — present
- AfiRx, LLCPrincipalcurrent2022 — presentBrookline, Massachusetts, United States
- Lyndra TherapeuticsChief Technology Officer2020 — 2022Massachusetts, United States
- Moderna TherapeuticsHead of Delivery Sciences2013 — 2020Cambridge, MA
- AlkermesVice President2008 — 2013
- Transform PharmaceuticalsSenior Director2000 — 2008
- J&J PRDSenior Director, early drug product development US2005 — 2008
- MerckResearch Fellow / group leader preformulation1995 — 2000
Skills & more
Formulation Development8Pharmaceuticals4Chemistry35Biotechnology40Analytical Chemistry42R&D32Product Development12Drug Delivery25Drug Discovery74Pharmaceutical Industry72Formulation55Commercialization7
+5 more
LifesciencesCharacterizationBiopharmaceuticalsDrug DevelopmentPharmaceuticsLanguages Danish · German
From Orn's professional profile.
Frequently asked questions
- Who is Orn Almarsson?
- Executive Officer, Director, Promoter at Axelyf
- Where does Orn Almarsson work?
- Orn Almarsson is Founder of Axelyf.
- What companies did Orn Almarsson found?
- Orn Almarsson founded Axelyf.
- Where did Orn Almarsson go to school?
- Orn Almarsson studied at UC Santa Barbara (Doctor of Philosophy (Ph.D.), Bioorganic chemistry); Harvard Business School (Leadership and Strategy in Biotech and Pharma); Massachusetts Institute of Technology (Postdoc, non-aqueous enzymology).
Same school
Also attended UC Santa Barbara437
Logan GreenCo-founder of LyftJen WangDeal Operations Manager at Felicis VenturesArturo LitvinHead of Global Portfolio Development at Intel CapitalKevin ThauInvestor at Spark CapitalErica DelamareInvestor at DaphniDanielle RomanowskiExecutive Assistant at Sapphire Ventures
+ 431 more
Also attended Harvard Business School2,000
Brad GerstnerFounder & CEO of Altimeter CapitalVictoria TreygerGeneral Partner at Felicis VenturesDeep NisharInvestment Team at General CatalystJohn KimInvestor Relations at General CatalystAdrianna MaInvestor at Index VenturesNeil RimerInvestor at Index Ventures
+ 1,994 more
Also attended Massachusetts Institute of Technology2,000
Hemant TanejaCEO & Managing Director of General CatalystNat FriedmanCo-lead of Meta Superintelligence Labs; co-founder of NFDGBrad FeldCo-founder of Foundry and TechstarsMatt HuangCo-founder and Managing Partner at ParadigmDelian AsparouhovPartner at Founders Fund and co-founder of VardaDrew HoustonCo-founder & CEO of Dropbox
+ 1,994 more
Also attended Háskóli Íslands30
Hrönn GreipsdóttirCEO at New Business Venture FundFriðrik FriðrikssonCFO at New Business Venture FundThomas KrauseManaging Director at Brandenburg KapitalÁrni BlöndalFounding Partner at Brunnur Ventures GPÁsthildur OtharsdóttirGeneral Partner at Frumtak VenturesAndri Heiðar KristinssonGeneral Partner at Frumtak Ventures
+ 24 more
Shared employers
Also worked at UNSW79
Mike Cannon-BrookesCo-founder & CEO of AtlassianKate MasonVenture Partner at AirTree VenturesDaphne ShenChief of Staff at AirTree VenturesJosh CondousIT & Security Manager at AirTree VenturesKylie FrazerCo-Founder at Flying Fox VenturesVictor HaPartner at Quadrant Private Equity Pty Ltd.
+ 73 more
Also worked at Moderna Therapeutics23
Dave JohnsonCo-founder & CEO of Dash BioNoubar AfeyanInvestor at Flagship PioneeringGisella de la RochaVice President of Legal at MPM BioImpactAxel BouchonVenture Partner at ARCH Venture PartnersJordan SilvaCampus Lead at The MBA FundLee CooperManaging Director at Delos Capital
+ 17 more
Also worked at Alkermes8
Haley LeversedgeInvestor at Silversmith Capital PartnersMaria V Lopez-BresnahanInvestment Advisory Committee at 3CC | Third Culture CapitalMark RosenblumExecutive Vice President, Chief Financial Officer at Salarius PharmaceuticalsLloyd JohnstonExecutive Officer at Cartesian Therapeutics (NASDAQ: RNAC)Mary DiBiaseExecutive Officer at X4 PharmaceuticalsKeith MurphyExecutive Officer, Director at Viscient Bio
+ 2 more
